Elutia
43 employees on LinkedIn · 1 known investors
Find your way into Elutia
13 people in our graph share verified history with the Elutia team — schools, employers, funds. One of them is your warm intro.
Maria Millanunlockedknows C. Randal Mills · together at California Institute for Regenerative Medicine (overlapped)
×2knows the team · via California Institute for Regenerative Medicine
×2knows the team · via RTI Surgical (formerly Regeneration Technologies, Inc)
×6knows the team · via Sanford Burnham Prebys Medical Discovery Institute
knows the team · via Be The Match
Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.
Founders & leadership
CR
C. Randal MillsinFounder, President & CEODr. Randal Mills holds a doctorate in tissue sterilization and has held CEO roles at Osiris Therapeutics (where he oversaw approval of a stem cell therapeutic and commercialized cell therapy products) and Be The Match; he previously served as President of the California Institute for Regenerative Medicine and is co-founder and CEO of Elutia.
Investors · 1
Frequently asked questions
- What does Elutia do?
- Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.
- Who founded Elutia?
- Elutia was founded by C. Randal Mills.
- Who are Elutia's investors?
- Elutia's investors include HighCape Capital.